hero section gradient
15 handpicked stocks

Navigating Persistent Inflation

Recent data shows inflation remains stubbornly high, reducing the likelihood of Federal Reserve rate cuts. This environment favors companies with strong pricing power that can protect their profit margins by passing increased costs to consumers.

Author avatar

Han Tan | Market Analyst

Published on July 31

Your Basket's Financial Footprint

Summary and investor takeaways based on the basket's market capitalisation breakdown.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and closer tracking of broad market movements.
  • Suited as a core holding for diversified portfolios, not a speculative or high-conviction trade.
  • Expect steadier long-term value rather than rapid, short-term gains; growth is likely moderate.
Total Market Cap
  • PEP: $209.45B

  • PSMT: $3.74B

  • INGR: $7.71B

  • Other

About This Group of Stocks

1

Our Expert Thinking

With inflation proving more persistent than expected and the Federal Reserve likely to delay rate cuts, we've focused on companies with exceptional pricing power. These businesses can successfully pass rising costs to consumers without losing demand, protecting their profit margins in challenging economic conditions.

2

What You Need to Know

This group features companies with strong brand loyalty, essential products, or dominant market positions that give them the ability to raise prices when input costs increase. They're designed to be defensive plays during inflationary periods when many businesses struggle to maintain profitability.

3

Why These Stocks

Each company was handpicked by professional analysts for their proven ability to navigate inflationary environments. They represent businesses that have historically maintained or grown their margins during periods of rising costs, making them tactical allocations for uncertain economic times.

Why You'll Want to Watch These Stocks

🛡️

Inflation-Proof Businesses

These companies have proven they can maintain profitability even when costs rise, making them valuable defensive plays in uncertain economic times.

💪

Pricing Power Advantage

With strong brand loyalty and essential products, these businesses can raise prices without losing customers, protecting their margins when inflation strikes.

📈

Fed Policy Hedge

As the Federal Reserve keeps rates higher for longer to combat inflation, these stocks offer a tactical way to navigate the challenging monetary environment ahead.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Automotive Semiconductor Gap Explained | Market Shift

Automotive Semiconductor Gap Explained | Market Shift

A major semiconductor supplier's export ban from China is halting vehicle production, creating a potential opening for other chip manufacturers. This theme identifies alternative semiconductor companies poised to fill the critical supply gap for the automotive industry.

Brazil Smart Farming Tech Investment Basket 2025

Brazil Smart Farming Tech Investment Basket 2025

As Brazil solidifies its role as a global agricultural leader, advanced technologies are unlocking new levels of productivity and sustainability for its farms. This basket offers exposure to the US and EU-listed companies providing the essential hardware, software, and data analytics driving this transformation.

Weight-Loss Drug M&A: Valuation Risk Concerns

Weight-Loss Drug M&A: Valuation Risk Concerns

Novo Nordisk's superior bid for Metsera has ignited a bidding war with Pfizer, highlighting the intense M&A activity in the obesity drug market. This theme focuses on other biotech companies with promising weight-loss therapies that could become the next acquisition targets.

Frequently Asked Questions